Al. Jacobs et al., HEPARIN HEPARAN SULFATE INTERACTING PROTEIN EXPRESSION AND FUNCTIONS IN HUMAN BREAST-CANCER CELLS AND NORMAL BREAST EPITHELIAL/, Cancer research, 57(22), 1997, pp. 5148-5154
Heparin/heparan sulfate interacting protein (HIP) is a recently identi
fied protein expressed by many normal epithelia and epithelial cell li
nes, In the present study, we examined expression and potential functi
ons of this protein in a series of human breast cancer cells and in se
ctions of normal and malignant human breast tissue, Four of the five b
reast cancer cell lines studied (MCP-7, T-47D, MDA-MB468, and BT-549)
expressed HIP protein and mRNA at similar levels. In contrast, MDA-MB-
231 cells failed to display reactivity with HIP-specific probes in any
assay, Cell aggregation assays and cell surface antibody binding stud
ies demonstrated that HIP was expressed on the cell surface, However,
HIP expression did not correlate with the number of cell surface [H-3]
heparin (HP) binding sites. The K(Dapp)s for cell surface HP binding s
ites were similar in all breast cancer cell lines studied and ranged f
rom 112 to 298 nM, In contrast, cell surface HP binding capacity varie
d greatly, ranging from 2.3 x 10(5) (MDA-MB-231 and MDA-MB-468) to 99
x 10(5) sites/cell (BT-549), All cell lines tested displayed the abili
ty to bind to a heparan sulfate (HS)-binding synthetic peptide moth of
HIP in a HP-inhibitable fashion, Binding to this motif was not inhibi
ted by other glycosaminoglycans including hyaluronic acid, chondroitin
sulfates, or keratan sulfate, Furthermore, cell binding to HIP peptid
e was almost completely lost when intact cells were predigested with h
eparinases but not chondroitinases. Cell surface HS from breast cancer
cells as well as normal human breast epithelia binded to HIP peptide
in a HP-inhibitable fashion, demonstrating the ability of these cell s
urface components to directly interact, HIP was detected in both norma
l breast epithelia and breast tumors in situ. It is suggested that HIP
mediates aspects of HS-dependent interactions of both normal and mali
gnant breast epithelia with other cells and extracellular matrix compo
nents.